AMEX:ASXC   Asensus Surgical, Inc
-The shares of Asensus Surgical (NYSEMKT:ASXC) are heating up again among penny stock investors. The ASXC stock price increased as much as 8% in pre-market trading on Wednesday morning after new analyst coverage was announced.

-Asensus Surgical is a company pioneering “a new standard of surgery for increased control, less variability and consistently superior outcomes.” The company’s offerings are aimed at integrating machine learning and automated intelligence to improve surgical outcomes. Specifically, Asensus’ focus is on laparoscopic surgical procedures.

-Analysts at H.C. Wainwright initiated coverage on ASXC stock today with a “buy” rating. The coverage comes less than two weeks after Asensus released its first-quarter results, reporting revenue of $2.1 million as compared to $600,000 in the three months ended March 31, 2020. Revenue in the first quarter of 2021 included $1.3 million in its Senhance Surgical System sales, $400,000 in instruments and accessories, and $400,000 in services.

Join our Telegram channel to get daily trade signals, analyses, and financial education! 📈

Instagram: @caldooninvestment